Asthma Clinical Trial
Official title:
Quality of Life in Asthmatic Children at School Age : Influence of Therapeutic Education
Asthma is the most common chronic disease in childhood [1]. The advantage of an educational
program in a global strategy of care has been established in asthma (decrease of nocturnal
asthma, absence from work and school) [2, 3]. Therapeutic education of the patient permits
the reduction of the rate of hospitalization, of the rate of emergencies visits and
non-programmed visits. [3].
The WHO defines quality of life as an individual's perception of its place in existence, in
the context of culture and value system in which he lives, in relation to its objectives,
expectations, standards and concerns [4]. The basic point of this concept is the notion of
perception, emphasizing the perspective of the person. It is a broad concept affected in a
complex way by the subject's physical health, psychological state, level of independence,
social relationships, and its relations with its environment. In the field of health,
analyzing the quality of life includes objective aspects (living conditions, functional
health) and subjective aspects (satisfaction, happiness, well-being) that allow to
understand the situation of people in whole.
As defined by the WHO-Europe report published in 1996 [5], the therapeutic education aims to
help patients acquire or maintain the competencies they need to best manage their lives with
a chronic disease.
It is entirely part of the management of the patient. It includes organized activities
designed to make patients aware and informed of their disease, of care organization and
hospital procedures, and the behaviors related to health and disease. This is to help them
and their families understand their illness and treatment, to work together and to gain
autonomy from their disease in order to help maintain and improve their quality of life [6].
However, studies demonstrating the effectiveness of therapeutic patient education are still
very few, especially in children. The need for prospective studies including the evaluation
of the impact on quality of life was highlighted in a recent Cochrane meta-analysis [7]. It
seems interesting for the authors to assess the improvement of the quality of life after
educational sessions in children at school-age.
Longitudinal prospective study ;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|